Researchers have developed a cutting-edge technique that uses RNA “barcodes” to map how neurons connect, capturing thousands ...

Near-infrared spectroscopy, or fNIRS, offers a way to monitor brain activity without surgery or radiation by tracking changes in blood flow and oxygenation. Light sources placed on the scalp send near ...

Alice Chawner has had five surgeries since an MRI scan revealed she had a brain tumor after the fall Lexi Lane is a weekend banking writer at PEOPLE. She first joined as a member of the PEOPLE App ...

Researchers say they’ve discovered a supply-chain attack flooding repositories with malicious packages that contain invisible code, a technique that’s flummoxing traditional defenses designed to ...

PCWorld reports that Anthropic’s Claude Code AI assistant now features voice mode, allowing developers to control the coding tool through verbal commands. Currently rolling out to 5% of users with ...

The term “brain tumor” carries a particularly scary connotation. And if you’re a fan of TV medical dramas, you may think they’re quite common. However, less than 1% of Americans are living with a ...

The oldest brother of an 11-year-old U.S. citizen girl whose treatment for a rare brain tumor was interrupted when her parents were deported to Mexico is attending the State of the Union address ...

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease. By Rebecca Robbins and Gina Kolata A ...

Free AI tools Goose and Qwen3-coder may replace a pricey Claude Code plan. Setup is straightforward but requires a powerful local machine. Early tests show promise, though issues remain with accuracy ...

Goose acts as the agent that plans, iterates, and applies changes. Ollama is the local runtime that hosts the model. Qwen3-coder is the coding-focused LLM that generates results. If you've been ...

A central nervous system (CNS) tumor has prompted the FDA to place clinical holds on two Regenxbio gene therapies, including a candidate that is less than two weeks away from an approval decision.